Accelerate Your Large Molecule Development with CMIC Inc.
Your Trusted Partner in Large Molecule Bioanalysis
Large Molecule Solutions
In the dynamic landscape of drug development, precision and speed are paramount. When it comes to large molecules, including Gene Therapies, Antibody Drug Conjugates (ADCs), Monoclonal Antibodies (mAbs), Bispecifics, Antibody Oligonucleotide Conjugates, Fusion Proteins, Enzymes, Nanoparticles, and Vaccines, CMIC stands out as a leading Contract Research Organization (CRO). Our commitment to delivering high-quality data, ensuring rapid turnaround times, and minimizing surprises sets us apart in the competitive realm of large molecule bioanalysis.
What are Large Molecules?
Large molecule bioanalysis refers to the analytical techniques and processes used to study and quantify large molecules, particularly biopharmaceuticals, in biological matrices. It also includes immunogenicity assessment of the anti-drug antibodies that can develop against these molecules. Large molecules in the context of bioanalysis typically include proteins, peptides, nucleic acids (such as DNA and RNA), and other macromolecules. These molecules play a crucial role in advanced therapeutic approaches for biologics and gene therapies.
Connect with CMIC on your latest Large Molecule projects
Why CMIC for Large Molecule Bioanalysis?
Proven Track Record
At CMIC, we pride ourselves on a proven track record of consistently delivering accurate and reliable results within tight timelines. In the fast-paced world of drug development, where go/no-go decisions can make or break a project, our commitment to on-time delivery ensures you stay ahead of the competition.
Expert Team
Our success is built on the expertise of our team. From molecular and cellular biology to analytical chemistry, our technical experts bring a comprehensive understanding of key therapeutic areas, including oncology, immuno-oncology, immunology, and neurosciences. This breadth of knowledge allows us to navigate the complexities of large molecule bioanalysis with confidence.
Assay Development Excellence
CMIC excels in developing and validating the most demanding and challenging assays within specified deadlines. Whether you’re working on gene therapies, ADCs, mAbs, nanoparticles, or vaccines, our proficiency in bioanalytical testing ensures that you have the data you need to evaluate pharmacokinetics, pharmacodynamics, safety, and efficacy throughout the drug development process.
Accelerate Your Timeline with CMIC’s Top-Line Instruments
Our commitment to excellence is further reinforced by our state-of-the-art instrumentation. We utilize cutting-edge technology to ensure the highest quality results. Some of our top-line instruments include:
